Dietary whey protein lessens several risk factors for metabolic diseases: a review.

Abstract

Obesity and type 2 diabetes mellitus (DM) have grown in prevalence around the world, and recently, related diseases have been considered epidemic. Given the high cost of treatment of obesity/DM-associated diseases, strategies such as dietary manipulation have been widely studied; among them, the whey protein diet has reached popularity because it has been suggested as a strategy for the prevention and treatment of obesity and DM in both humans and animals. Among its main actions, the following activities stand out: reduction of serum glucose in healthy individuals, impaired glucose tolerance in DM and obese patients; reduction in body weight; maintenance of muscle mass; increases in the release of anorectic hormones such as cholecystokinin, leptin, and glucagon like-peptide 1 (GLP-1); and a decrease in the orexigenic hormone ghrelin. Furthermore, studies have shown that whey protein can also lead to reductions in blood pressure, inflammation, and oxidative stress.

• Authors: Gabriela T D Sousa, Fábio S Lira, José C Rosa, Erick P de Oliveira, Lila M Oyama, Ronaldo V Santos, Gustavo D Pimentel
• Journal: Lipids in health and disease (Lipids Health Dis) Vol. 11 Pg. 67 (Jul 10 2012) ISSN: 1476-511X [Electronic] England
• PMID: 22676328 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Dietary Proteins
• Milk Proteins
• Whey Proteins

Topics

• Animals
• Diabetes Mellitus, Type 2 (prevention & control)
• Dietary Proteins (therapeutic use)
• Humans
• Milk Proteins (therapeutic use)
• Obesity (prevention & control)
• Risk Factors
• Whey Proteins